AblaCare provides an innovative solution to Polycystic Ovary Syndrome (PCOS) related infertility, where they avail more natural and less medicalized pregnancy experience to patients. The Paris-based startup focuses on restoring ovulation in PCOS patients via simplified, one-time, long-lasting, and less-invasive treatment.
Health Care, Medical Device
Between €5 million-€10 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as AblaCare? We’re happy to assist you with our Startup Sourcing service.